There's a simple test for any healthcare AI promising to save time: Does the doctor actually use it? MiiHealth AI, a Phoenix startup building voice-driven patient intake systems, just passed an early version of that exam—though perhaps the harder questions lie ahead.
More than 200 patients at Mayo Clinic Arizona spoke with the company's AI agent, DAINA, during a pilot targeted to be completed by mid-October 2025. According to a Phoenix Business Journal article, over 90% of users rated the experience highly. CEO Kelvin Summoogum told the Phoenix Business Journal that the collaboration aimed to refine DAINA's capabilities before any broader rollout, a measured framing that underscores how tentative even promising pilots remain in an industry littered with proof-of-concept cul-de-sacs.
Still, Mayo's name carries weight. And for a startup that relocated from London to Phoenix's Bioscience Core only last September, the validation matters—especially as MiiHealth works to close the gap between the $590,000 it had raised by March 2026 ($550,000 in dilutive funding and $40,000 in non-dilutive funding, per the Flinn Foundation's Arizona Bioscience Week directory) and the $1.5 million it was seeking.
The company has since secured additional capital, though it hasn't disclosed the amount. What it has disclosed: patient satisfaction numbers that, if they hold, suggest DAINA might actually fit into clinical workflows rather than complicate them. According to MiiHealth, the system saves eight minutes per patient visit and scores 93% on ease-of-use ratings, based on more than 300 interactions across two cardiology workflows in Arizona. Eight minutes doesn't sound transformative until you multiply it across a dozen appointments—suddenly, that's two hours returned to a cardiologist's day.
A voice interface with an English summary
DAINA's design reflects a pragmatic understanding of provider realities. Patients can speak in multiple languages, but the system spits out clinical summaries in English—a choice that avoids the thornier problem of asking time-strapped physicians to navigate multilingual documentation. The platform handles specialty-specific intake for cardiology, orthopedics, and oncology, with MiiHealth claiming it can ship customized workflows in about two weeks. Whether that agility survives contact with the entrenched IT bureaucracies of large health systems remains to be seen.
The company has also deployed its technology as part of a veterans project with Blue Bell Behavioral Health in Casa Grande, supported by Arizona's Health Innovation Trust Fund, according to the state's 2025 annual report published in May 2026.
MiiHealth operates from Mayo Boulevard in Phoenix, nestled inside the Discovery Oasis ecosystem. LinkedIn shows the company has between 2 and 10 employees as of August 2026. Co-founders include Summoogum and Jacob Lester, with John Wall as Chief Product Officer. It's a lean structure, which is either a sign of disciplined burn or a signal that the company is still finding its footing.
Capital piecemeal, ecosystem everywhere
Funding has come in chunks. MiiHealth raised $200,000 through a special purpose vehicle in April 2025, then another $150,000 via a second SPV that September, according to SEC filings. The company holds Qualified Small Business certification from Arizona Commerce Authority, making it eligible for the state's angel investor tax credit program—a useful carrot for local backers.
On the ecosystem front, MiiHealth has collected badges. It joined NVIDIA's Inception program in July 2026 and cycled through accelerators including Arizona State University's Innovation Open Challenge, Propel@YH, Microsoft AI for Good, and Plug and Play Alberta. The company presented at the AZAdvances Health Innovation Showcase in April 2026. These are table stakes for a healthtech startup in 2026, but they also suggest MiiHealth is working the room—building relationships that might eventually convert into contracts or follow-on capital.
A crowded field, a specific bet
The competitive landscape for AI-powered intake has gotten noisy fast. Kin Health raised $9 million in May 2026 for a patient-side notetaker. Earlier this year, Jimini Health pulled in $17 million seed funding for behavioral health AI, while Dandelion Health secured a $14 million Series A for precision medicine infrastructure. Multilingual intake specifically has attracted players like Hilt Health (which supports 130-plus languages), MIRA, and Saaya—each offering voice or web-based alternatives to clipboard medicine.
What sets MiiHealth apart, if anything, is the Mayo pilot and its focus on specialty-specific workflows rather than a one-size-fits-all intake form. The company is making a bet that customization and clinical validation matter more than raw feature lists.
Proving it scales
The question now is repeatability. Pilot results are one thing; sustained deployment across health systems with varying IT stacks, patient demographics, and bureaucratic inertia is another. MiiHealth will need to show that its time-savings claims hold up outside Arizona cardiology clinics and that the platform can integrate with the thicket of legacy EHR systems most hospitals still run.
Summoogum has signaled hiring ambitions, though the team remains small. That's understandable—unit economics need to pencil out before scaling headcount. But it also means MiiHealth is racing to prove traction before the next funding milestone becomes urgent. The Mayo results offer a clinical reference point. Whether they translate into a revenue engine depends on how many health systems are willing to bet that a conversation with an AI can actually lighten the load rather than add another tool to ignore.
For now, MiiHealth has momentum, a marquee partner, and a product that at least some patients seem willing to talk to. In healthcare AI, that's further than most get.
